3
Announcements
Trials
Browse
Landscape
Status
Recruiting
2
Withdrawn
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Breast
2
Conditions
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Recurrence
1
Radiation Injuries
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Cholangiocarcinoma
1
Cervical Cancer Susceptible Population Classification
1
Biliary Tract Neoplasms
1
Interventions
Fulvestrant
60
Capecitabine
47
Trastuzumab
46
Letrozole
45
pembrolizumab
42
Carboplatin
41
Paclitaxel
39
Cyclophosphamide
38
ribociclib
37
abemaciclib
36
pertuzumab
34
Blood Specimen Collection
31
Specimen Handling
28
trastuzumab deruxtecan
27
Surveys and Questionnaires
26
Docetaxel
26
Tamoxifen
25
Anastrozole
25
exemestane
24
palbociclib
21
130-nm albumin-bound paclitaxel
21
Magnetic Resonance Spectroscopy
20
Biopsy
19
sacituzumab govitecan
18
eribulin
18
Radiotherapy
18
Gemcitabine
18
olaparib
17
Injections
17
Epirubicin
17
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Breast Neoplasms
×
Base Sequence
×
Clear all
NCT05652569
2026-01-28
CATCH
German Cancer Research Center
Recruiting
5,000 enrolled
NCT05906407
2025-03-19
COGNITION
German Cancer Research Center
Recruiting
2,000 enrolled